Clinical trials
Phase 1/2 Neoplasms trials in Greece
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 5 |
| Completed | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hellenic Oncology Research Group | 2 |
| Hellenic Society of Hematology | 2 |
| GlaxoSmithKline | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Revolution Medicines, Inc. | 1 |
| Stemline Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 8 |
| Blood Protein Disorders | 2 |
| Corneal Diseases | 2 |
| Hematologic Diseases | 2 |
| Multiple Myeloma | 2 |
| Neoplasms, Plasma Cell | 2 |
| Ovarian Neoplasms | 2 |
| Paraproteinemias | 2 |
| Brain Diseases | 1 |
| Brain Neoplasms | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.